Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease
- PMID: 29391398
- PMCID: PMC5804029
- DOI: 10.1038/s41398-017-0030-5
Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease
Abstract
Schizophrenia (SCZ) is a neuropsychiatric disorder with a complex genetic etiology. The redundancy of the gene networks underlying SCZ indicates that many gene combinations have the potential to cause a system dysfunction that can manifest as SCZ or a related neurodevelopmental disorder. Recent studies show that small non-coding microRNA (miRNA) and long non-coding RNA (lncRNA) are important factors in shaping these networks and are dynamically regulated by neuronal activation. We investigated the genome-wide transcription profiles of 46 human amygdala samples obtained from 22 SCZ patients and 24 healthy controls. Using RNA sequencing (RNA-seq), we determined lncRNA expression levels in all samples and generated miRNA profiles for 27 individuals (13 cases and 14 controls). Previous studies have identified differentially expressed miRNAs in SCZ, including miR-132, miR-212, and miR-34a/miR-34c. Here we report differential expression of a novel miRNA, miR1307, in SCZ. Notably, miR1307 maps to a locus previously associated with SCZ through GWAS. Additionally, one lncRNA that was overexpressed in SCZ, AC005009.2, also maps to a region previously associated with SCZ based on GWAS and overlapped SCZ-related genes. The results were replicated in a large independent data set of 254 dorsolateral prefrontal cortex samples from the CommonMind consortium. Taken together, these results suggest that miRNA and lncRNAs are important contributors to the pathogenesis of SCZ.
Conflict of interest statement
Ethical approval
This study had been approved by the Children’s Hospital of Philadelphia with IRB# 4886. All the patients who participated in this project have been consented and they agree to publish the results.
Competing interests
The authors declare that they have no competing financial interests.
Figures
References
-
- Picchioni MM, Murray RM. Schizophrenia. Br. Med. J. 2007;335:91–95. doi: 10.1136/bmj.39227.616447.BE. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 MH096891/MH/NIMH NIH HHS/United States
- R37 MH057881/MH/NIMH NIH HHS/United States
- R01 MH075916/MH/NIMH NIH HHS/United States
- R01 MH097284/MH/NIMH NIH HHS/United States
- RC2 MH089924/MH/NIMH NIH HHS/United States
- U01 HG008684/HG/NHGRI NIH HHS/United States
- P50 MH084053/MH/NIMH NIH HHS/United States
- HHSN271201300031C/DA/NIDA NIH HHS/United States
- U54 HD086984/HD/NICHD NIH HHS/United States
- P50 MH066392/MH/NIMH NIH HHS/United States
- R01 MH080405/MH/NIMH NIH HHS/United States
- R01 MH085542/MH/NIMH NIH HHS/United States
- R01 MH097276/MH/NIMH NIH HHS/United States
- P01 AG002219/AG/NIA NIH HHS/United States
- R01 MH093725/MH/NIMH NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
